Key people at Inovexus.
Inovexus is a community-based cross-border acceleration fund focused on investing in and accelerating early-stage B2B tech startups with global ambitions. It unites entrepreneur-investors and provides startups with customized support, mentorship from top global experts, and access to a network of over 2,000 smart investors and 250+ mentors. The fund operates primarily across Europe, Asia, and the US, aiming to build a rapidly growing portfolio of impactful technology startups while fostering the largest cross-border community of early-stage investors and entrepreneurs. Their acceleration program emphasizes business growth, product development, recruitment, and fundraising, boasting a 90% survival rate for portfolio companies[1][3][6].
Founded in the US with a global vision, Inovexus emerged to disrupt the early-stage funding market by addressing the needs of European B2B tech startups seeking rapid global funding and acceleration. The firm was established by a team of experienced partners including former senior executives from Accenture, Microsoft France, Sony Pictures Entertainment, Netflix, and venture capital leaders. Over time, Inovexus has evolved into a unique VC club-accelerator model that combines investment with a strong community and tailored acceleration services, expanding its footprint across multiple countries and sectors[1][2][4].
Inovexus rides the trend of globalization and digitization in early-stage tech investing, leveraging the rise of cross-border funding platforms and syndicates. The timing is critical as startups increasingly require rapid access to smart capital and global expertise to scale beyond local markets. Market forces such as the proliferation of deal clubs, the demand for specialized acceleration, and the growth of B2B tech innovation favor Inovexus’s model. By bridging investors and founders across continents, Inovexus influences the ecosystem by fostering international collaboration, accelerating startup growth, and democratizing access to capital and mentorship[1][2][4][5].
Looking ahead, Inovexus is poised to expand its portfolio and deepen its global community, potentially increasing its influence in early-stage tech funding. Trends such as AI, climate tech, and SaaS will likely shape its investment focus. The firm’s emphasis on personalized acceleration and cross-border connectivity positions it well to capitalize on the growing need for startups to scale internationally. As the early-stage funding landscape continues to evolve with new platforms and investor models, Inovexus’s hybrid VC club-accelerator approach may become a blueprint for future investment funds aiming to combine capital with operational support and global reach[1][3][6].
Key people at Inovexus.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2023 | N99 | $1.0M Seed | — | — |
| Oct 1, 2022 | crowd.dev | $2.0M Seed | — | Atlassian Ventures, Bond, DN Capital, Felicis Ventures, Next47, Partech Ventures, Seedcamp, Theory Ventures, Damien Fretay, Mandeep Singh, Rand Hindi, Tim Sadler |
| Jul 1, 2022 | Alegria.tech | $3.0M Seed | — | 50 Partners Impact, DN Capital, ISAI, Damien Fretay, Rand Hindi |
| Feb 1, 2022 | Hyperion | $1.0M Seed | — | — |
| Nov 1, 2021 | EasyExpunctions | $6.0M Series A | — | Active Capital, SNR, Damien Fretay, Matt Brezina |
| May 1, 2021 | N99 | $210K Seed | — | Clement Benoit |
| May 1, 2021 | ASTUCORP | $430K Seed | — | Damien Fretay |
| Mar 1, 2021 | Art Data | $700K Seed | — | Damien Fretay |
| Nov 1, 2020 | Madeinvote | $1.0M Seed | — | Damien Fretay |
| Apr 1, 2020 | Amai Proteins | $1.0M Seed | — | — |
| Dec 1, 2017 | CORE FOR TECH | $2.0M Seed | — | — |
